Get the Stockscreener App
299.71
3.72%
-11.25
Overview
News
Price History
Option Chain
Financials
Why LRCX Down?
Discussions
Forecast
Stock Split
Dividend History
Lam Research Corp stock is traded at $299.71, with a volume of 641.86K.
It is down -3.72% in the last 24 hours and down -4.65% over the past month.
Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.
See More
Previous Close:
$310.96
Open:
$307.5
24h Volume:
641.86K
Relative Volume:
0.06
Market Cap:
$375.20B
Revenue:
$21.68B
Net Income/Loss:
$6.71B
P/E Ratio:
56.57
EPS:
5.298
Net Cash Flow:
$6.00B
1W Performance:
+11.20%
1M Performance:
-4.65%
6M Performance:
+28.32%
1Y Performance:
+126.93%
1-Day Range:
$298.56
$309.75
1-Week Range:
$266.90
$311.39
52-Week Range:
$125.02
$438.50
Lam Research Corp Stock (LRCX) Company Profile
Name
Lam Research Corp
Sector
Phone
(510) 659-0200
Address
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
299.84 | 389.11B | 21.68B | 6.71B | 6.00B | 5.298 |
ASML
Asml Holding Nv
|
1,711.98 | 671.37B | 41.20B | 12.41B | 11.15B | 32.12 |
AMAT
Applied Materials Inc
|
463.04 | 374.94B | 29.02B | 8.51B | 5.34B | 10.64 |
KLAC
Kla Corp
|
182.58 | 246.05B | 13.09B | 4.67B | 4.01B | 3.5373 |
TER
Teradyne Inc
|
384.40 | 62.33B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-26 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-05-26 | Initiated | Seaport Research Partners | Buy |
| Apr-02-26 | Downgrade | Erste Group | Buy → Hold |
| Jan-29-26 | Upgrade | Summit Insights | Hold → Buy |
| Jan-29-26 | Reiterated | TD Cowen | Buy |
| Jan-15-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-15-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-23-25 | Reiterated | TD Cowen | Buy |
| Sep-30-25 | Initiated | HSBC Securities | Hold |
| Sep-29-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-23-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-22-25 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Sep-02-25 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-14-25 | Resumed | Erste Group | Buy |
| Jul-31-25 | Downgrade | Summit Insights | Buy → Hold |
| Jul-31-25 | Reiterated | TD Cowen | Buy |
| Jul-10-25 | Initiated | Goldman | Buy |
| Apr-24-25 | Reiterated | TD Cowen | Buy |
| Mar-20-25 | Resumed | Oppenheimer | Outperform |
| Feb-20-25 | Upgrade | Susquehanna | Neutral → Positive |
| Jan-30-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-30-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-17-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-15-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Dec-17-24 | Initiated | Cleveland Research | Neutral |
| Aug-01-24 | Reiterated | TD Cowen | Buy |
| May-13-24 | Initiated | Jefferies | Buy |
| Apr-25-24 | Reiterated | TD Cowen | Buy |
| Apr-19-24 | Upgrade | B. Riley Securities | Neutral → Buy |
| Apr-18-24 | Reiterated | Needham | Buy |
| Apr-16-24 | Initiated | Evercore ISI | Outperform |
| Apr-11-24 | Resumed | Deutsche Bank | Hold |
| Jan-25-24 | Reiterated | TD Cowen | Outperform |
| Jan-23-24 | Initiated | Cantor Fitzgerald | Neutral |
| Dec-12-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-08-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-22-23 | Initiated | Redburn Atlantic | Buy |
| Oct-17-23 | Initiated | Raymond James | Outperform |
| Oct-13-23 | Upgrade | Needham | Hold → Buy |
| Sep-15-23 | Initiated | Wolfe Research | Outperform |
| Jul-24-23 | Reiterated | Mizuho | Buy |
| Jul-24-23 | Upgrade | Stifel | Hold → Buy |
| Apr-20-23 | Reiterated | Berenberg | Buy |
| Apr-20-23 | Reiterated | Evercore ISI | Outperform |
| Apr-20-23 | Reiterated | JP Morgan | Overweight |
| Apr-20-23 | Reiterated | Jefferies | Buy |
| Apr-20-23 | Reiterated | Mizuho | Buy |
| Apr-20-23 | Reiterated | Stifel | Hold |
| Apr-20-23 | Reiterated | Wells Fargo | Equal Weight |
| Mar-13-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jan-18-23 | Resumed | Stifel | Hold |
| Dec-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-20-22 | Reiterated | B. Riley Securities | Neutral |
| Oct-20-22 | Reiterated | BofA Securities | Buy |
| Oct-20-22 | Reiterated | DA Davidson | Neutral |
| Oct-20-22 | Reiterated | Evercore ISI | Outperform |
| Oct-20-22 | Reiterated | JP Morgan | Overweight |
| Oct-20-22 | Reiterated | Jefferies | Buy |
| Oct-20-22 | Upgrade | Summit Insights | Hold → Buy |
| Oct-20-22 | Reiterated | Wells Fargo | Equal Weight |
| Jul-25-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Jun-15-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jan-27-22 | Reiterated | Barclays | Overweight |
| Jan-27-22 | Reiterated | Deutsche Bank | Hold |
| Jan-27-22 | Reiterated | Evercore ISI | Outperform |
| Jan-27-22 | Reiterated | Stifel | Buy |
| Jan-27-22 | Reiterated | Susquehanna | Neutral |
| Jan-27-22 | Reiterated | UBS | Buy |
| Jan-26-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-12-22 | Reiterated | Barclays | Overweight |
| Jan-10-22 | Reiterated | BofA Securities | Buy |
| Jan-05-22 | Resumed | Jefferies | Buy |
| Dec-15-21 | Reiterated | Deutsche Bank | Hold |
| Oct-21-21 | Reiterated | B. Riley Securities | Buy |
| Oct-21-21 | Downgrade | Summit Insights | Buy → Hold |
| Oct-15-21 | Initiated | Piper Sandler | Neutral |
| Sep-14-21 | Downgrade | Susquehanna | Positive → Neutral |
| Sep-07-21 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Jul-29-21 | Reiterated | Mizuho | Buy |
| Jul-29-21 | Reiterated | Stifel | Buy |
| Jul-29-21 | Reiterated | UBS | Buy |
| Jul-29-21 | Reiterated | Wells Fargo | Equal Weight |
| Mar-31-21 | Initiated | Bernstein | Outperform |
| Jan-28-21 | Reiterated | Cowen | Outperform |
| Jan-08-21 | Downgrade | Needham | Buy → Hold |
| Dec-17-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-22-20 | Reiterated | Goldman | Buy |
| Oct-22-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Oct-22-20 | Reiterated | Mizuho | Buy |
| Oct-22-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-22-20 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-22-20 | Reiterated | Stifel | Buy |
| Oct-22-20 | Reiterated | UBS | Buy |
| Sep-21-20 | Upgrade | Stifel | Hold → Buy |
| Jul-30-20 | Reiterated | Cowen | Outperform |
| Jul-21-20 | Upgrade | B. Riley FBR | Neutral → Buy |
| Jun-22-20 | Downgrade | Stifel | Buy → Hold |
| Jun-16-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-26-20 | Initiated | Barclays | Overweight |
| Apr-23-20 | Reiterated | Needham | Buy |
| Apr-08-20 | Initiated | Exane BNP Paribas | Outperform |
| Apr-03-20 | Upgrade | Nomura | Neutral → Buy |
| Apr-02-20 | Downgrade | DA Davidson | Buy → Neutral |
| Mar-27-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-27-20 | Upgrade | UBS | Sell → Buy |
View All
Lam Research Corp Stock (LRCX) Latest News
Lam Research (NASDAQ:LRCX) Trading Up 2.9%What's Next? - MarketBeat
Lam Research Corporation $LRCX Shares Acquired by Andra AP fonden - MarketBeat
State Street Corp Grows Position in Lam Research Corporation $LRCX - MarketBeat
LRCX Eyes Mid-40s Operating Margin: Is the Long-Term Goal Achievable? - Zacks Investment Research
Lam Research Corp (LRCX) Stock Up 4.9% but GF Value Says Overval - GuruFocus
Lam Research Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Lam Research Corp Stock (LRCX) Moved Up by 3.58% on Sep 21: Drivers Behind the Movement - TradingKey
Lam Research Stock Rises as Analysts Lift AI Capex Outlook - timothysykes.com
Lam Research and MicroStrategy among market cap stock movers on Friday - Investing.com Canada
Is Lam Research Corp (LRCX) Overvalued After 7.0% Rally? GF Valu - GuruFocus
Lam Research advances 7%, reversing some recent losses (LRCX:NASDAQ) - Seeking Alpha
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Chip equipment stocks surge as Lam Research lea... - Pluang
Lam Research Climbs 5% as Chip Equipment Names Outrun the Sector; Applied Materials Rises 4%, KLA Corp. Gains 3% - Yahoo Finance
Lam Research Corp Stock (LRCX) Opened Up by 4.12% on Sep 18: Facts Behind the Movement - TradingKey
What's Going On With Lam Research Stock Friday? - Benzinga
442,227 Shares in Lam Research Corporation $LRCX Acquired by Nykredit A S - MarketBeat
Lam Research stock heads into the open after a 0.1% Nasdaq gain - AD HOC NEWS
U.S.-based Lam Research to invest ₹10,000 cr to scale up its India footprint - The Hindu
Lam Research Falls as Sector Risk-Off Trade Appears to Outweigh Recent Company Positives - Moomoo
Lam Research (NASDAQ:LRCX): Affordable Growth With Elite Profitability - ChartMill
Applied Materials, Lam Research Pledge Billions for India Chip Industry - marketscreener.com
Market Chatter: Applied Materials, Lam Research Pledge Billions for India Chip Industry - Moomoo
Lam Research stock heads into the open after a 0.6% Nasdaq dip - AD HOC NEWS
Lam Research Corporation $LRCX Stock Position Lifted by Bank of America Corp DE - MarketBeat
Lam Research (NASDAQ:LRCX) Stock Price Down 8.3%Time to Sell? - MarketBeat
Lam Research Corp. stock underperforms Monday when compared to competitors - MarketWatch
Lam Research Corp Stock (LRCX) Moved Down by 6.91% on Sep 14: What Signal Does It Send? - TradingKey
Lam Research Corporation Share PriceLRCX, RNS News, Articles, Quotes, & Charts (NASDAQ:LRCX) - Proactive financial news
Lam Research Lifts 2026 WFE Outlook as AI Demand Strains Fab Capacity - Yahoo Finance
Lam Research Corporation $LRCX Shares Acquired by The Manufacturers Life Insurance Company - MarketBeat
Lam Research stock heads into the open after a 5.6% drop - ad-hoc-news.de
Lam Research stock heads into the open after a 5.7% drop - ad-hoc-news.de
Lam Research Corp (LRCX) Shares Fall 5.7% -- What GF Score of 85 Tells Investors - GuruFocus
Lam Research CEO Timothy Archer sells $9.58 million in company stock By Investing.com - Investing.com Australia
Here's How Much $100 Invested In Lam Research 20 Years Ago Would Be Worth Today - Benzinga
Lam Research CEO Timothy Archer sells $9.58 million in company stock - Investing.com Australia
Lam Research Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Lam Research director Bethany Mayer sells $3m in shares By Investing.com - Investing.com South Africa
Lam Research director Bethany Mayer sells $3m in shares - investing.com
Lam Research at Goldman Sachs conference: demand stays red hot By Investing.com - Investing.com UK
Lam Research Insider Sold Shares Worth $9,577,800, According to a Recent SEC Filing - Moomoo
Lam Research (NASDAQ: LRCX) CEO exercises options and sells 30,000 shares - Stock Titan
Lam Research (NASDAQ: LRCX) director sells shares with no preset trading plan disclosed - Stock Titan
Lam Research Corp Stock (LRCX) Opened Down by 3.98% on Sep 10: What Signal Does It Send? - TradingKey
Lam Research Returns $5B+ to Shareholders in FY26: Can It Reward More? - Yahoo Finance
Lam Research (LRCX) Benefits From Memory Expansion - Yahoo Finance
Rench Wealth Management Inc. Trims Stake in Lam Research Corporation $LRCX - MarketBeat
IFP Advisors Inc Acquires 4,186 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation at Goldman Sachs Communacopia + Technology Conference Transcript - GuruFocus
Lam Research stock heads into the open after a Nasdaq-led drop - ad-hoc-news.de
Lam Research Corp Stock (LRCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lam Research Corp Stock (LRCX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ARCHER TIMOTHY | President and CEO |
Sep 09 '26 |
Sale |
319.26 |
30,000 |
9,577,800 |
1,075,966 |
| Mayer Bethany | Director |
Sep 09 '26 |
Sale |
314.74 |
9,557 |
3,007,970 |
20,995 |
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):